Manufacturer
Blueprint Medicines
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 5
- Molecules
- 1
- Therapy areas
- 1
Blueprint Medicines is a pharmaceutical manufacturer based in United States. MedsAcross lists 5 of its products across 1 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Blueprint Medicines Corporation
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Blueprint Medicines products through licensed channels, with the documents your regulator needs.
Oncology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Ayvakit 100 mg tabletOral | Avapritinib | US FDA | Available on request |
| Ayvakit 200 mg tabletOral | Avapritinib | US FDA | Available on request |
| Ayvakit 25 mg tabletOral | Avapritinib | US FDA | Available on request |
| Ayvakit 300 mg tabletOral | Avapritinib | US FDA | Available on request |
| Ayvakit 50 mg tabletOral | Avapritinib | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Blueprint Medicines
Send a request for any of these products. We confirm the licensed source, documents and lead time.